Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. (Q51034393)
Jump to navigation
Jump to search
scientific article published in May 1996
Language | Label | Description | Also known as |
---|---|---|---|
English | Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. |
scientific article published in May 1996 |
Statements
1 reference
Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. (English)
1 reference
Kobayashi T
1 reference
Nakanishi K
1 reference
Murase T
1 reference
Kosaka K
1 reference
1 May 1996
1 reference
1 reference
45
1 reference
5
1 reference
622-626
1 reference
Identifiers
1 reference
1 reference